Adhera Therapeutics, Inc. | Business Contracts

Form of Security Agreement (Filed With SEC on January 26, 2023)

Employment Agreement dated June 29, 2022 between Adhera Therapeutics, Inc. and Zahed Subhan (Filed With SEC on August 15, 2022)

Second Addendum to the License Agreement (Filed With SEC on August 4, 2022)

Description of Securities (Filed With SEC on April 14, 2020)

Settlement Agreement, dated April 4, 2019, by and between Adhera Therapeutics, Inc. and Robert R. Moscato, Jr (Filed With SEC on April 5, 2019)

Form of Securities Purchase Agreement (Filed With SEC on January 26, 2023)

Form of Warrant (Filed With SEC on January 26, 2023)

Form of Original Issue Discount Senior Secured Promissory Note (Filed With SEC on January 26, 2023)

Form of Security Agreement dated May 11, 2022 (Filed With SEC on May 16, 2022)

Form of Warrant dated May 11, 2022 (Filed With SEC on May 16, 2022)

Form of Senior Secured Original Issue Discount Promissory Note dated May 11, 2022 (Filed With SEC on May 16, 2022)

Form of Securities Purchase Agreement dated May 11, 2022 (Filed With SEC on May 16, 2022)

License Agreement between Adhera Therapeutics, Inc. and Melior Pharmaceuticals I, LLC dated August 20, 2021 (Filed With SEC on April 15, 2022)

Form of Convertible Redeemable Promissory Note issued by Adhera Therapeutics, Inc. to select accredited investors on March 15, 2022 (Filed With SEC on April 15, 2022)

Addendum to License Agreement Adhera Therapeutics, Inc. and Melior Pharmaceuticals I, LLC dated August 20, 2021 dated February 16, 2022 (Filed With SEC on April 15, 2022)

Form of Securities Purchase Agreement issued by Adhera Therapeutics, Inc. to select accredited investors on March 15, 2022 (Filed With SEC on April 15, 2022)

Form of Securities Purchase Agreement (Filed With SEC on November 12, 2021)

Form of Warrant (Filed With SEC on November 12, 2021)

Form of 10% Convertible Redeemable Note (Filed With SEC on November 12, 2021)

Form of Warrant (Filed With SEC on October 13, 2021)

Form of 10% Convertible Redeemable Note (Filed With SEC on October 13, 2021)

Form of Securities Purchase Agreement (Filed With SEC on October 13, 2021)

Form of Securities Purchase Agreement (Filed With SEC on August 24, 2021)

Form of Warrant (Filed With SEC on August 24, 2021)

Form of Convertible Promissory Note (Filed With SEC on August 24, 2021)

Form of Common Stock Purchase Warrants issued by Adhera Therapeutics, Inc. to select accredited investors on June 25, 2021 (Filed With SEC on August 23, 2021)

Form of Convertible Promissory Note issued by Adhera Therapeutics, Inc. to select accredited investors on June 25, 2021 (Filed With SEC on August 23, 2021)

Form of Warrant (Filed With SEC on August 18, 2021)

Form of Convertible Promissory Note (Filed With SEC on August 18, 2021)

License Agreement (Filed With SEC on August 4, 2021)

Form of Warrant (Filed With SEC on April 23, 2021)

Form of Convertible Promissory Note (Filed With SEC on April 23, 2021)

Form of Warrant (Filed With SEC on February 9, 2021)

Form of Convertible Promissory Note (Filed With SEC on February 9, 2021)

Form of Warrant (Filed With SEC on November 5, 2020)

Form of Senior Secured Convertible Note (Filed With SEC on November 5, 2020)

Consulting Agreement between Company and Andrew Kucharchuk (Filed With SEC on July 13, 2020)

Security Agreement dated June 26, 2020 (Filed With SEC on June 30, 2020)

Form of Convertible Promissory Note (Filed With SEC on June 30, 2020)

Securities Purchase Agreement dated as of February 5, 2020 between Adhera Therapeutics, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on February 11, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on February 11, 2020)

Form of Convertible Promissory Note (Filed With SEC on February 11, 2020)

Employment Agreement, dated as of October 29, 2019, by and between Adhera Therapeutics, Inc. and Rhonda Stanley (Filed With SEC on November 4, 2019)

Form of Subscription Agreement (Filed With SEC on August 7, 2019)

Form of Secured Promissory Note (Filed With SEC on July 3, 2019)

Security Agreement, dated as of June 28, 2019, among Adhera Therapeutics, Inc., IThenaPharma, Inc., Cequent Pharmaceuticals, Inc., MDRNA Research, Inc., the purchasers of secured... (Filed With SEC on July 3, 2019)

2018 Long-Term Incentive Plan of the Registrant (Filed With SEC on April 16, 2019)

Form of Subscription Agreement used in connection with the offering of the Series F Convertible Preferred Stock of the Registrant (Filed With SEC on April 16, 2019)

Employment Agreement, dated April 4, 2019, by and between Adhera Therapeutics, Inc. and Nancy R. Phelan (Filed With SEC on April 5, 2019)

Adhera Therapeutics, Inc. (49)